First Time Loading...

Kyorin Holdings Inc
TSE:4569

Watchlist Manager
Kyorin Holdings Inc Logo
Kyorin Holdings Inc
TSE:4569
Watchlist
Price: 1 817 JPY -2.15% Market Closed
Updated: Mar 28, 2024

Intrinsic Value

KYORIN Holdings, Inc. engages in the development, manufacture and sale of pharmaceutical products through its subsidiaries. [ Read More ]

The intrinsic value of one Kyorin Holdings Inc stock under the Base Case scenario is 1 790.14 JPY. Compared to the current market price of 1 817 JPY, Kyorin Holdings Inc is Overvalued by 1%.

Key Points:
Intrinsic Value
Base Case
1 790.14 JPY
Overvaluation 1%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Kyorin Holdings Inc

Backtest Kyorin Holdings Inc Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling Kyorin Holdings Inc stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Financials

Balance Sheet Decomposition
Kyorin Holdings Inc

Current Assets 120.5B
Cash & Short-Term Investments 19.1B
Receivables 44B
Other Current Assets 57.4B
Non-Current Assets 58.4B
Long-Term Investments 21.3B
PP&E 28.8B
Intangibles 5.1B
Other Non-Current Assets 3.2B
Current Liabilities 47.6B
Accounts Payable 14.2B
Accrued Liabilities 1.1B
Short-Term Debt 10.1B
Other Current Liabilities 22.2B
Non-Current Liabilities 4.8B
Long-Term Debt 485m
Other Non-Current Liabilities 4.3B
Efficiency

Earnings Waterfall
Kyorin Holdings Inc

Revenue
119.8B JPY
Cost of Revenue
-68.4B JPY
Gross Profit
51.4B JPY
Operating Expenses
-46.5B JPY
Operating Income
4.9B JPY
Other Expenses
-619m JPY
Net Income
4.3B JPY

Free Cash Flow Analysis
Kyorin Holdings Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

Profitability Score
Profitability Due Diligence

Kyorin Holdings Inc's profitability score is 47/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Years Revenue Growth
Positive 1-Year Revenue Growth
Positive Revenue Growth Forecast
47/100
Profitability
Score

Kyorin Holdings Inc's profitability score is 47/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Kyorin Holdings Inc's solvency score is 83/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
Low D/E
Long-Term Solvency
High Altman Z-Score
83/100
Solvency
Score

Kyorin Holdings Inc's solvency score is 83/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Kyorin Holdings Inc

Wall Street analysts forecast Kyorin Holdings Inc stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Kyorin Holdings Inc is 1 785 JPY with a low forecast of 1 515 JPY and a high forecast of 2 100 JPY.

Lowest
Price Target
1 515 JPY
17% Downside
Average
Price Target
1 785 JPY
2% Downside
Highest
Price Target
2 100 JPY
16% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

Price
Kyorin Holdings Inc

1M 1M
+2%
6M 6M
-2%
1Y 1Y
+8%
3Y 3Y
-2%
5Y 5Y
-3%
10Y 10Y
+18%
Annual Price Range
1 817
52w Low
1 678.2415
52w High
1 853
Price Metrics
Average Annual Return -2.89%
Standard Deviation of Annual Returns 6.97%
Max Drawdown -30%
Shares Statistics
Market Capitalization 104.4B JPY
Shares Outstanding 57 303 900
Percentage of Shares Shorted
N/A

Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Kyorin Holdings Inc Logo
Kyorin Holdings Inc

Country

Japan

Industry

Pharmaceuticals

Market Cap

104.4B JPY

Dividend Yield

3.45%

Description

KYORIN Holdings, Inc. engages in the development, manufacture and sale of pharmaceutical products through its subsidiaries. The company is headquartered in Chiyoda-Ku, Tokyo-To and currently employs 2,243 full-time employees. The company went IPO on 2006-03-10. The firm operates through two business segments. The Pharmaceuticals segment is engaged in the manufacture, purchase and sales of pharmaceutical products, the evaluation of technologies, the inspection, analysis and negotiation of license affiliations, as well as the research of new drugs and candidate compounds. The company also engages in the purchase and sales of medical promotion tools and packaging materials. The Healthcare segment is engaged in the manufacturing, sales and purchase of environmental sanitation products, general purpose medicines and skin care products.

Contact

TOKYO-TO
Chiyoda-ku
16F, Ochyanomizu Sola City, 4-6, Kanda Surugadai
+81335254700.0
http://www.kyorin-gr.co.jp/

IPO

2006-03-10

Employees

2 243

Officers

President, CEO & Representative Director
Mr. Yutaka Ogihara
Executive Officer, CStO, CFO & GM of Corporate Planning Department
Yasuji Kurose
Executive Officer and CHRO in charge of HR Dept., General Affairs Dept., Legal & Compliance Dept.
Mr. Yasuyuki Shimokawa
Executive Director & CMO
Mr. Michiro Onota
Executive Officer, Head of Business Development Division & CBDO
Takaaki Kaji
Executive Officer, CCO & GM of Pharmaceutical Sales Division
Noriaki Tamura
Show More
Executive Officer, CSO & GM of Drug Discovery Division
Junichi Ishiyama
Executive Officer, President & Representative Director of Kyorin Rimedio Co., Ltd.
Mr. Hiroshi Hashizume
Executive Officer & Tokyo Branch Manager
Tetsuo Tatsumi
Executive Officer
Tokutaro Yasue
Show Less

See Also

Discover More
What is the Intrinsic Value of one Kyorin Holdings Inc stock?

The intrinsic value of one Kyorin Holdings Inc stock under the Base Case scenario is 1 790.14 JPY.

Is Kyorin Holdings Inc stock undervalued or overvalued?

Compared to the current market price of 1 817 JPY, Kyorin Holdings Inc is Overvalued by 1%.